NRAS and melanoma: Recently, miRNome and proteome profiling of extracellular vesicles (EVs) isolated from BRAF- or NRAS-mutant melanoma cells cultured under hypoxia revealed distinct changes in several factors that could potentially be tested as biomarkers for melanoma progression.